Get the Stockscreener App
0.641
0.25%
-0.0016
After Hours:
.6637
0.0227
+3.54%
Traws Pharma Inc stock is currently priced at $0.641, with a 24-hour trading volume of 54,712.
It has seen a -0.25% decreased in the last 24 hours and a -6.11% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.6459 pivot point. If it approaches the $0.6317 support level, significant changes may occur.
Previous Close:
$0.6426
Open:
$0.6426
24h Volume:
54,712
Market Cap:
$16.22M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.71%
1M Performance:
-6.11%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1D Range:
$0.633
$0.6637
52W Range:
$0.601
$0.7288
Traws Pharma Inc Stock (TRAW) Company Profile
Name
Traws Pharma Inc
Sector
Industry
Phone
267-759-3681
Address
375 PHEASANT RUN, NEWTOWN
Traws Pharma Inc Stock (TRAW) Latest News
Traws Pharma's High-Stakes Merger: The Race Against Time for Financial Success - TipRanks.com - TipRanks
TipRanks
Traws Pharma Announces First Quarter Financial Results and Progress in Respiratory and Oncology Programs - MSN
MSN
Traws Pharma Announces First Quarter Financial Results and Progress in Respiratory and Oncology Programs - MyChesCo
MyChesCo
Traws Pharma earnings missed, revenue fell short of estimates - Investing.com South Africa
Investing.com South Africa
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Traws Pharma Inc Stock (TRAW) Financials Data
There is no financial data for Traws Pharma Inc (TRAW). Check out other stocks for more information.
About Traws Pharma Inc
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
0.77%
1.20%
Cap:
|
Volume (24h):